REporting recommendations for tumour MARKer prognostic studies (REMARK)
Top Cited Papers
- 31 August 2005
- journal article
- guideline
- Published by Elsevier BV in European Journal of Cancer
- Vol. 41 (12), 1690-1696
- https://doi.org/10.1016/j.ejca.2005.03.032
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A Systematic Review of Molecular and Biological Tumor Markers in NeuroblastomaClinical Cancer Research, 2004
- Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the futureBritish Journal of Cancer, 2003
- A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma familyEuropean Journal of Cancer, 2003
- Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD InitiativeClinical Chemistry, 2003
- Potential for Selection Bias with Tumor Tissue Retrieval in Molecular Epidemiology StudiesAnnals of Epidemiology, 2002
- Sensitivity of HER-2/neu Antibodies in Archival Tissue Samples of Invasive Breast CarcinomasAmerican Journal of Clinical Pathology, 2000
- Predicting the future: a critical appraisal of cancer prognosis studiesHistopathology, 1999
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Criteria for prognostic factors and for an enhanced prognostic systemCancer, 1993
- Why do so many prognostic factors fail to pan out?Breast Cancer Research and Treatment, 1992